Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2002
08/07/2002EP0829473B1 Processes for preparing cyclic compounds
08/07/2002CN1362960A Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones
08/07/2002CN1362947A N-cyanomethylamides as protease inhibitors
08/07/2002CN1362640A Silver-halides photo-sensitive emulsion layer with reinforced photographic photosensibility
08/07/2002CN1362397A Dialkoyl-halogen phenyl substituted keto-enol
08/07/2002CN1088709C Amine compound and its acid addition salt
08/07/2002CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments
08/07/2002CN1088585C Compound active at novel site on receptor-operated calcium channels use full for treatment of neurological disorders and diseases
08/06/2002US6429317 Indane derivatives for antipsychotic compositions
08/06/2002US6429221 Inhibitors of tumor necrosis factor; used to treat cachexia, endotoxic shock, and retrovirus replication
08/06/2002US6429212 Aminopeptidase n inhibitor used to treat cancer, tumors, and retinopathy; few side effects; angiogenesis inhibitor
08/06/2002US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/06/2002CA2231812C Cyclic nitrones and pharmaceutical compositions containing them
08/06/2002CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides
08/01/2002WO2002059165A2 Polymerization of olefinic compounds
08/01/2002WO2002059124A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/01/2002WO2002059122A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO[3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM
08/01/2002WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/01/2002WO2002059108A1 Melanocortin receptor agonists
08/01/2002WO2002059107A1 Substituted piperidines/piperazines as melanocortin receptor agonists
08/01/2002WO2002059095A1 Melanocortin receptor agonists
08/01/2002WO2002059092A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
08/01/2002WO2002059089A2 Process for the preparation of heterocyclic indene analogs
08/01/2002WO2002059088A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/01/2002WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
08/01/2002WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002WO2002058679A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
08/01/2002WO2002032285A3 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients
08/01/2002WO2001078697A3 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
08/01/2002WO2001078654A3 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
08/01/2002US20020103383 Selective 5-HT6 receptor ligands
08/01/2002US20020103382 Serotonin (5-HT) subtype 6 receptor (5-HT6); 3-(2-aminoethyl)indole derivatives; drug screening
08/01/2002US20020103248 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal
08/01/2002US20020103247 Indole and dihydroindole derivatives
08/01/2002US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same
08/01/2002US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids
08/01/2002US20020103197 For use in protecting human and animal hair and skin against damaging action of UV radiation
08/01/2002US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone
08/01/2002US20020103188 Peroxisome Proliferator-Activated Receptors (PPAR); diabetes and obesity; 3-(4-(2-(10,1-Dihydro-dibenzo(b,f)azepin-5-yl)ethoxy)-pheny)-2-ethoxy -propionic acid, for example
08/01/2002US20020103164 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
08/01/2002US20020102608 Library of indolinone compounds for use in the treatment of cancer
08/01/2002CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002CA2435653A1 Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium
08/01/2002CA2435633A1 Antiangiogenic compounds and an assay for inhibitors of cell invasion
08/01/2002CA2435566A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/01/2002CA2433025A1 Substituted piperidines/piperazines as melanocortin receptor agonists
08/01/2002CA2432988A1 Melanocortin receptor agonists
08/01/2002CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/01/2002CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
08/01/2002CA2431996A1 Melanocortin receptor agonists
07/2002
07/31/2002EP1227095A2 A process for the purification of (S)-4-((3-(dimethylamino)ethyl)-1H-indol-5yl)-methyl)-2-oxazolidinone
07/31/2002EP1226138A1 Fab i inhibitors
07/31/2002EP1226121A1 Method of inhibiting neurotrophin-receptor binding
07/31/2002EP1226120A2 Benz[f]indoles for use in the treatment of 5ht receptor related disorders
07/31/2002EP1226116A1 Processes for the preparation of sumatriptan and related compounds
07/31/2002EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors
07/31/2002EP1225895A1 Fab i inhibitors
07/31/2002EP1225894A1 Fab i inhibitors
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP1225882A1 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
07/31/2002EP0764152B1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
07/31/2002EP0719267B1 Second messenger cell signaling inhibitors
07/31/2002CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
07/31/2002CN1361716A Preparation and use of ionic liquids in microwave-assisted chemical transformation
07/31/2002CN1361100A New heterocyclic derivative and its medical use
07/30/2002US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia
07/30/2002US6426344 Aryl and heteroaryl substituted indolealkanoic acids
07/30/2002CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives
07/30/2002CA2093353C Hydrolytically and oxidatively stable polyimides
07/30/2002CA2078039C Process for the production of lactams
07/25/2002WO2002057231A2 Benz(g) indoles and their use as spla2 inhibitors
07/25/2002WO2002057216A1 Terphenyl compounds bearing substituted amino groups
07/25/2002WO2002038545A3 Crystalline ethanolate solvate form of zafirlukast, process for manufacture and pharmaceutical compositions thereof
07/25/2002WO2002032901A3 Bridged piperazine derivatives
07/25/2002WO2002030867A3 Drugs for diabetes
07/25/2002WO2001070222A3 Compounds with 5-ht1a activity useful for treating disorders of the outer retina
07/25/2002WO2001040188A9 Curcumin analogues for treating cancer
07/25/2002US20020099224 Hydrolysis of [R (R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
07/25/2002US20020099223 Cyclocarbonylating acetic acid (or benzoic acid)-1-(1-benzenesulfonyl-1H-indol-2-yl)-allyl ester to obtain 9-benzenesulfonyl-9H-carbazol-4-yl ester; saponifying
07/25/2002US20020099208 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
07/25/2002US20020099096 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer
07/25/2002US20020099084 Pharmaceutically active compounds and methods of use
07/25/2002US20020099080 Indole derivatives useful A.O. for the treatment of osteoporosis
07/25/2002US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
07/25/2002US20020099054 2-phenyl benzimidazole derivatives as MCP-1 antagonists
07/25/2002DE10130830A1 Indol-Derivate Indole derivatives
07/25/2002DE10102944A1 Production of 3-cyano-1H-indol-7-yl)-(4-(4-fluorophenethyl)piperazin-1-yl)-methanone useful as a selective 5-HT2A antagonist comprises use of an indolecarboxylic acid ester as the starting material
07/25/2002CA2431506A1 Benz(g) indoles and their use as spla2 inhibitors
07/24/2002EP1225169A1 Radiation-activated cytotoxin therapy
07/24/2002EP1224170A1 6-position substituted indoline, production and use thereof as a medicament
07/24/2002EP1224169A2 Production of 5-substituted indolinones and use thereof as medicaments
07/24/2002EP1224168A1 Antifungal enediynes
07/24/2002EP1224165A1 Novel compounds
07/24/2002EP1223929A1 Cannabimimetic indole derivatives
07/24/2002EP0885230B1 Camptothecin derivatives and the use thereof as antitumor agents
07/24/2002EP0859759B1 Sulphonic acids and their use as u/v absorbers
07/24/2002CN1360580A Substd. benzoyl ketones, methods for producing them and their use as herbicides
07/24/2002CN1360576A Process for preparation of spiro [(4-cyclohexanone)-[3H] indol]-2'[iH]-one derivs.
07/24/2002CN1360575A Process for preparation of spiro-[cis-4-(beta-hydroxyethyloxy) cyclohexane-(3H) indol]-2'[1'H]-one derivs.